MRD Monitoring in Acute Lymphoblastic Leukemia

0 vistas
administrator
administrator
06/15/23

In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.

  • categoría

Mostrar más

0 Comentarios Ordenar por

No se encontraron comentarios

Comentarios de Facebook

Hasta la próxima